Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) EPS (Basic) (2020 - 2026)

Lucid Diagnostics posted quarterly EPS (Basic) of -$0.17 for Q1 2026, up 67.31% year-on-year from -$0.1 in Q1 2025, and down 70.0% on a QoQ basis from -$0.1 in Q4 2025.

Lucid Diagnostics (LUCD) has 7 years of EPS (Basic) data on file, last reported at -$0.17 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 67.31% year-over-year to -$0.17; the trailing twelve-month figure through Mar 2026 stood at -$0.45 (up 61.86% YoY), and the FY2025 full-year result was -$0.69, up 34.29% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.17, down from -$0.1 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.08 in Q2 2025 and bottomed at -$0.52 in Q1 2025.
  • The 5-year median for EPS (Basic) is -$0.27 (2023), against an average of -$0.28.
  • The widest annual swing landed in 2022, when EPS (Basic) sank 34.62%; it then jumped 67.31% in 2026.
  • A 5-year view of EPS (Basic) shows it stood at -$0.4 in 2022, then surged by 37.5% to -$0.25 in 2023, then advanced by 28.0% to -$0.18 in 2024, then surged by 44.44% to -$0.1 in 2025, then tumbled by 70.0% to -$0.17 in 2026.
  • The last three EPS (Basic) figures came in at -$0.17 (Q1 2026), -$0.1 (Q4 2025), and -$0.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.62
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.95
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.52
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.25
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 -0.17

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.17
Dec 31, 2025 -0.10
Sep 30, 2025 -0.10
Jun 30, 2025 -0.08
Mar 31, 2025 -0.52
Dec 31, 2024 -0.18
Sep 30, 2024 -0.25
Jun 30, 2024 -0.23
Mar 31, 2024 -0.40
Dec 31, 2023 -0.25
Sep 30, 2023 -0.34
Jun 30, 2023 -0.27
Mar 31, 2023 -0.40
Dec 31, 2022 -0.40
Sep 30, 2022 -0.39
Jun 30, 2022 -0.41
Mar 31, 2022 -0.35
Dec 31, 2021 -0.32
Sep 30, 2021 -0.49
Jun 30, 2021 -0.44
Mar 31, 2021 -0.26
Dec 31, 2020 -0.20
Sep 30, 2020 -0.14